Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukihiko Shirayama

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 3, 2006
[The problems of the current antidepressants and their future possibilities]Yukihiko Shirayama
Biological Psychiatry|February 8, 2018
What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?Kenji Hashimoto, Yukihiko Shirayama
Current Neuropharmacology|July 26, 2008
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsYukihiko Shirayama, Shigeyuki Chaki
The International Journal of Neuropsychopharmacology|November 21, 2017
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-KetamineYukihiko Shirayama, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|August 3, 2016
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depressionYukihiko Shirayama, Kenji Hashimoto
Journal of Clinical Psychopharmacology|September 2, 2011
Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trialYukihiko Shirayama, Takeshi Konishi, Kenji Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2012
[Antidepressants]Masatoshi Suzuki, Koichi Sato, Yukihiko Shirayama
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|June 30, 2009
Altered levels of synapsin I, dopamine transporter, dynorphin A, and neuropeptide Y in the nucleus accumbens and striatum at post-puberty in rats treated neonatally with pregnenolone or DHEAKatsumasa Muneoka, Masaaki Iwata, Yukihiko Shirayama
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 18, 2006
Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patientsHideaki Mitani, Yukihiko Shirayama, Takeshi Yamada, et al.
Neurochemical Research|August 30, 2008
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in ratsKatsumasa Muneoka, Yukihiko Shirayama, Morikuni Takigawa, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 3, 2006
[The problems of the current antidepressants and their future possibilities]Yukihiko Shirayama
Biological Psychiatry|February 8, 2018
What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?Kenji Hashimoto, Yukihiko Shirayama
Current Neuropharmacology|July 26, 2008
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsYukihiko Shirayama, Shigeyuki Chaki
The International Journal of Neuropsychopharmacology|November 21, 2017
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-KetamineYukihiko Shirayama, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|August 3, 2016
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depressionYukihiko Shirayama, Kenji Hashimoto
Journal of Clinical Psychopharmacology|September 2, 2011
Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trialYukihiko Shirayama, Takeshi Konishi, Kenji Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2012
[Antidepressants]Masatoshi Suzuki, Koichi Sato, Yukihiko Shirayama
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|June 30, 2009
Altered levels of synapsin I, dopamine transporter, dynorphin A, and neuropeptide Y in the nucleus accumbens and striatum at post-puberty in rats treated neonatally with pregnenolone or DHEAKatsumasa Muneoka, Masaaki Iwata, Yukihiko Shirayama
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 18, 2006
Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patientsHideaki Mitani, Yukihiko Shirayama, Takeshi Yamada, et al.
Neurochemical Research|August 30, 2008
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in ratsKatsumasa Muneoka, Yukihiko Shirayama, Morikuni Takigawa, et al.
Pageof 12